Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Marc Humbert, Gabor Kovacs, Marius M. Hoeper, Roberto Badagliacca, Rolf M. F. Berger, Margarita Brida, Jorn Carlsen, Andrew J. S. Coats, Pilar Escribano-Subias, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Meszaros, Blin Nagavci, Karen M. Olsson, Joanna Pepke-Zaba, Göran Radegran, Gerald Simonneau, Oliver Sitbon, Thomy Tonia, […]

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Read More »

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival

Guillermo Torres, Andrew C. Lancaster, Jun Yang, Megan Griffiths, Stephanie Brandal, Rachel Damico, Dhananjay Vaidya, Catherine E. Simpson, Lisa J. Martin, Michael W. Pauciulo, William C. Nichols, D. Dunbar Ivy, Eric D. Austin, Paul M. Hassoun, Allen D. EverettJohns Hopkins University. University of Texas Southwestern Medical Center. Cincinnati Children’s Hospital Medical Center and University of

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival Read More »

Congenital and acquired pulmonary vein stenosis

Larry A. Latson, Lourdes R. PrietoCleveland Clinic FoundationUnited States CirculationCirculation 2007; 115: 103-108DOI: 10.1161/CIRCULATIONAHA.106.646166 AbstractNo Abstract Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary HypertensionSurgical and Catheter-mediated Interventions for Pulmonary Vascular DiseaseDiagnostic Testing for Pulmonary Vascular Disease. Non-invasive TestingDiagnostic Testing for Pulmonary Vascular Disease. Invasive TestingReview Articles Concerning Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular Disease

Congenital and acquired pulmonary vein stenosis Read More »

The emerging roles of SUMOylation in pulmonary diseases

Xuyang Zheng, Lingqiao Wang, Zhen Zhang, Huifang TangThe Affiliated Hangzhou First People’s Hospital, Zhejiang Respiratory Drugs Research Laboratory and Zhejiang University School of Medicine. China Molecular MedicineMol Med 2023; 29: DOI: 10.1186/s10020-023-00719-1 AbstractSmall ubiquitin-like modifier mediated modification (SUMOylation) is a critical post-translational modification that has a broad spectrum of biological functions, including genome replication and repair,

The emerging roles of SUMOylation in pulmonary diseases Read More »

Incidence of Pulmonary and Respiratory Conditions in Gaucher Disease from 2000 to 2020: A Multi-institutional Cohort Study

Yu-Nan Huang, Jing-Yang Huang, Wen-Ling Liao, Shang-Lun Chiang, Kai-Wen Liu, Da-Tian Bau, Chung-Hsing Wang, Pen-Hua SuChung Shan Medical University Hospital. China Medical University Hospital. I-Shou University. Children’s Hospital of China Medical University. Taiwan In VivoIn Vivo 2023; 37: 2276-2283DOI: 10.21873/invivo.13330 AbstractBackground/aim: Gaucher disease (GD) is a rare lysosomal storage disorder that can involve the lungs and pulmonary

Incidence of Pulmonary and Respiratory Conditions in Gaucher Disease from 2000 to 2020: A Multi-institutional Cohort Study Read More »

Management of pulmonary arterial hypertension during pregnancy

Kaushiga Krishnathasan, Andrew Constantine, Isma Rafiq, Ana Barradas Pires, Hannah Douglas, Laura C. Price, Konstantinos DimopoulosRoyal Brompton Hospital and Royal Brompton & Harefield Hospitals. Imperial College. St Thomas’ Hospital. King’s College.United Kingdom Expert Review of Respiratory MedicineExpert Rev Respir Med 2023; 17: 413-423DOI: 10.1080/17476348.2023.2210838 AbstractIntroduction: Pulmonary arterial hypertension (PAH) is defined as a mean pulmonary artery pressure

Management of pulmonary arterial hypertension during pregnancy Read More »

Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry

Megan Mayer, David B. Badesch, Kelly H. Nielsen, Steven Kawut, Todd Bull, John J. Ryan, Jeffrey Sager, Sula Mazimba, Anna Hemnes, James Klinger, James Runo, John W. McConnell, Teresa DeMarco, Murali M. Chakinala, Delphine Yung, Jean Elwing, Adolfo Kaplan, Rahul Argula, Raymond Pomponio, Ryan Peterson, Peter HountrasUniversity of Colorado. University of Pennsylvania. University of Utah.

Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry Read More »

Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play?

Adele Valentini, Paola Franchi, Giuseppe Cicchetti, Gaia Messana, Greta Chiffi, CeciliaStrappa, Lucio Calandriello, Annemiliadel Ciello, Alessandra Farchione, Lorenzo Preda, Anna Rita LariciFondazione IRCCS Policlinico San Matteo. G. Mazzini Hospital. Fondazione Policlinico Universitario. University of Pavia. Università Cattolica del Sacro Cuore. Italy DiagnosticsDiagnostics 2023; 13: DOI: 10.3390/diagnostics13091607 AbstractPulmonary hypertension (PH) is a pathophysiological disorder, defined by a

Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play? Read More »

Outcomes of pregnancy in mice with pulmonary hypertension induced by Hypoxia/SU5416

Yang Liu, Jing Deng, Yichen Zhao, Kemin Liu, Wenbo Zhang, Qiang Wang, Jiangang Wang, Chunmei PiaoBeijing Anzhen Hospital Affiliated to Capital Medical University. Yanbian University. Beijing Institute of Heart Lung and Blood Vessel Diseases. China Biochemical and Biophysical Research CommunicationsBiochem Biophys Res Commun 2023; 669: 128-133DOI: 10.1016/j.bbrc.2023.05.051 AbstractBackground: Pulmonary hypertension (PH) seriously affects the health of patients.

Outcomes of pregnancy in mice with pulmonary hypertension induced by Hypoxia/SU5416 Read More »

MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment

Łukasz Wołowiec, Martyna Medlewska, Joanna Osiak, Anna Wołowiec, Elzbieta Grzésk3 , Albert Jásniak, Grzegorz GrzéskNicolaus Copernicus University.Poland International Journal of Molecular SciencesInt J Mol Sci 2023; 24: DOI: 10.3390/ijms24119735 AbstractPulmonary hypertension (PH) is characterized by a progressive increase in pulmonary arterial pressure and pulmonary vascular resistance. In a short time, it leads to right ventricular failure

MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment Read More »

Scroll to Top